Gotham Asset Management LLC trimmed its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 51.9% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 330,643 shares of the pharmacy operator’s stock after selling 357,298 shares during the period. Gotham Asset Management LLC’s holdings in Walgreens Boots Alliance were worth $27,460,000 at the end of the most recent reporting period.
Other large investors have also recently made changes to their positions in the company. Hudock Capital Group LLC boosted its holdings in Walgreens Boots Alliance by 0.4% in the 1st quarter. Hudock Capital Group LLC now owns 1,300 shares of the pharmacy operator’s stock valued at $108,000 after purchasing an additional 5 shares during the period. Tarbox Group Inc. boosted its holdings in Walgreens Boots Alliance by 288.3% in the 1st quarter. Tarbox Group Inc. now owns 1,355 shares of the pharmacy operator’s stock valued at $113,000 after purchasing an additional 1,006 shares during the period. Webster Bank N. A. raised its position in shares of Walgreens Boots Alliance by 18.4% during the 1st quarter. Webster Bank N. A. now owns 1,509 shares of the pharmacy operator’s stock valued at $125,000 after buying an additional 235 shares in the last quarter. MCF Advisors LLC raised its position in shares of Walgreens Boots Alliance by 68.2% during the 1st quarter. MCF Advisors LLC now owns 1,923 shares of the pharmacy operator’s stock valued at $160,000 after buying an additional 780 shares in the last quarter. Finally, Founders Capital Management purchased a new stake in shares of Walgreens Boots Alliance during the 1st quarter valued at $161,000. 60.18% of the stock is owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY WARNING: “Gotham Asset Management LLC Sells 357,298 Shares of Walgreens Boots Alliance, Inc. (WBA)” was first published by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this report on another site, it was stolen and reposted in violation of United States and international trademark and copyright law. The legal version of this report can be viewed at https://ledgergazette.com/2017/09/16/gotham-asset-management-llc-sells-357298-shares-of-walgreens-boots-alliance-inc-wba.html.
Several analysts have recently weighed in on the stock. BidaskClub cut shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research report on Tuesday. Needham & Company LLC restated a “buy” rating and set a $94.00 price objective on shares of Walgreens Boots Alliance in a research report on Sunday, September 10th. Credit Suisse Group restated a “buy” rating and set a $97.00 price objective on shares of Walgreens Boots Alliance in a research report on Thursday, July 13th. UBS AG restated a “buy” rating and set a $96.00 price objective (down previously from $97.00) on shares of Walgreens Boots Alliance in a research report on Wednesday, August 23rd. Finally, Leerink Swann set a $86.00 price objective on shares of Walgreens Boots Alliance and gave the company a “buy” rating in a research report on Friday, July 7th. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and fourteen have assigned a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $91.81.
Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) traded up 0.60% during midday trading on Friday, reaching $82.50. 22,167,526 shares of the company’s stock were exchanged. The stock’s 50 day moving average is $81.26 and its 200-day moving average is $81.99. The stock has a market cap of $88.28 billion, a PE ratio of 20.83 and a beta of 1.26. Walgreens Boots Alliance, Inc. has a 12-month low of $75.18 and a 12-month high of $89.69.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Thursday, June 29th. The pharmacy operator reported $1.33 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.30 by $0.03. Walgreens Boots Alliance had a net margin of 3.69% and a return on equity of 17.34%. The business had revenue of $30.12 billion for the quarter, compared to the consensus estimate of $29.72 billion. During the same quarter in the prior year, the firm posted $1.18 earnings per share. The business’s revenue for the quarter was up 2.1% on a year-over-year basis. On average, equities analysts expect that Walgreens Boots Alliance, Inc. will post $5.00 EPS for the current year.
The company also recently announced a quarterly dividend, which was paid on Tuesday, September 12th. Stockholders of record on Friday, August 18th were paid a $0.40 dividend. The ex-dividend date of this dividend was Wednesday, August 16th. This represents a $1.60 annualized dividend and a dividend yield of 1.94%. This is an increase from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. Walgreens Boots Alliance’s dividend payout ratio is currently 40.30%.
Walgreens Boots Alliance declared that its board has approved a stock buyback program on Thursday, June 29th that authorizes the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization authorizes the pharmacy operator to reacquire up to 5.9% of its shares through open market purchases. Shares repurchase programs are often a sign that the company’s board of directors believes its stock is undervalued.
In other news, Director William C. Foote sold 2,736 shares of the stock in a transaction on Tuesday, July 25th. The shares were sold at an average price of $79.79, for a total value of $218,305.44. Following the sale, the director now owns 19,151 shares of the company’s stock, valued at $1,528,058.29. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 13.50% of the company’s stock.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.